TNFSF11 and periodontitis: In conclusion, based on this preclinical evidence, the RANK-RANKL-osteoprotegerin interactions and modulations may constitute an emerging therapeutic mediator for the treatment of periodontitis and alveolar bone loss, especially during the active phases of the disease.